A. Brynskikh

Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

A. Kabanov, E. Batrakova, T. Bronich, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Agile delivery of protein therapeutics to CNS.

Alexander V Kabanov, A. Kabanov, D. Manickam, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Effective transport coefficients of textured materials

E. A. Mityushov, P. V. Gel’d, A. Brynskikh, 1986 .

Cross-linked antioxidant nanozymes for improved delivery to CNS.

A. Kabanov, E. Batrakova, T. Bronich, 2012, Nanomedicine : nanotechnology, biology, and medicine.

SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.

A. Kabanov, Devika S-Manickam, A. Brynskikh, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

H. Gendelman, M. Boska, A. Kabanov, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Adaptive immunity affects learning behavior in mice

J. Kipnis, A. Brynskikh, Julia Zhu, 2008, Brain, Behavior, and Immunity.

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease.

H. Gendelman, M. Boska, A. Kabanov, 2010, Nanomedicine.